{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:16:19Z","timestamp":1789668979131,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T00:00:00Z","timestamp":1445990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Scientific and Technological Research Program of Chongqing Municipal Education Commission","award":["#CSTC 2012gg-yyis10002"],"award-info":[{"award-number":["#CSTC 2012gg-yyis10002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s13402-015-0251-7","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T11:56:15Z","timestamp":1446033375000},"page":"47-57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3\u2032-diindolylmethane in ovarian cancer cells"],"prefix":"10.1007","volume":"39","author":[{"given":"Minghua","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,28]]},"reference":[{"key":"251_CR1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"S. Vaughan, J.I. Coward, R.C. Bast Jr., A. Berchuck, J.S. Berek, J.D. Brenton, G. Coukos, C.C. Crum, R. Drapkin, D. Etemadmoghadam, M. Friedlander, H. Gabra, S.B. Kaye, C.J. Lord, E. Lengyel, D.A. Levine, I.A. McNeish, U. Menon, G.B. Mills, K.P. Nephew, A.M. Oza, A.K. Sood, E.A. Stronach, H. Walczak, D.D. Bowtell, F.R. Balkwill, Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer 11, 719\u2013725 (2011)","journal-title":"Nat Rev Cancer"},{"key":"251_CR2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s13402-014-0206-4","volume":"37","author":"Y Li","year":"2014","unstructured":"Y. Li, K. Wang, Y.Z. Jiang, X.W. Chang, C.F. Dai, J. Zheng, 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation. Cell Oncol 37, 429\u2013437 (2014)","journal-title":"Cell Oncol"},{"key":"251_CR3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13402-014-0174-8","volume":"37","author":"M Momeni","year":"2014","unstructured":"M. Momeni, T. Kalir, S. Farag, L. Chuang, D. Fishman, D.E. Burstein, Expression of H1. 5 and PLZF in granulosa cell tumors and normal ovarian tissues: a short report. Cell Oncol 37, 229\u2013234 (2014)","journal-title":"Cell Oncol"},{"key":"251_CR4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13402-013-0142-8","volume":"36","author":"J Di","year":"2013","unstructured":"J. Di, T. Duiveman-de Boer, P.L. Zusterzeel, C.G. Figdor, L.F.G. Massuger, R. Torensma, The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients. Cell Oncol 36, 363\u2013374 (2013)","journal-title":"Cell Oncol"},{"key":"251_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"R. Siegel, J. Ma, Z. Zou, A. Jemal, Cancer statistics, 2014. CA Cancer J Clin 64, 9\u201329 (2014)","journal-title":"CA Cancer J Clin"},{"key":"251_CR6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","volume":"3","author":"R Agarwal","year":"2003","unstructured":"R. Agarwal, S.B. Kaye, Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 3, 502\u2013516 (2003)","journal-title":"Nat Rev Cancer"},{"key":"251_CR7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1079\/BJN2003917","volume":"90","author":"S McNaughton","year":"2003","unstructured":"S. McNaughton, A, Marks G C, Development of a food composition database for the estimation of dietary intakes of glucosinolates, the biologically active constituents of cruciferous vegetables. Br J Nutr 90, 687\u2013697 (2003)","journal-title":"Br J Nutr"},{"key":"251_CR8","doi-asserted-by":"crossref","unstructured":"K. Kandala, P, K Srivastava S, DIMming ovarian cancer growth. Curr Drug Targets 13(1869\u20131875) (2012)","DOI":"10.2174\/138945012804545650"},{"key":"251_CR9","first-page":"94","volume":"6","author":"PK Kandala","year":"2012","unstructured":"P.K. Kandala, S.K. Srivastava, Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo. Drug Discov Ther 6, 94\u2013101 (2012)","journal-title":"Drug Discov Ther"},{"key":"251_CR10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.taap.2012.07.007","volume":"263","author":"LM Beaver","year":"2012","unstructured":"L.M. Beaver, T.W. Yu, E.I. Sokolowski, D.E. Williams, R.H. Dashwood, E. Ho, 3, 3\u2032-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells. Toxicol Appl Pharmacol 263, 345\u2013351 (2012)","journal-title":"Toxicol Appl Pharmacol"},{"key":"251_CR11","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1158\/0008-5472.CAN-09-0838","volume":"69","author":"S Banerjee","year":"2009","unstructured":"S. Banerjee, Z. Wang, D. Kong, F.H. Sarkar, 3, 3\u2032-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer. Cancer Res 69, 5592\u20135600 (2009)","journal-title":"Cancer Res"},{"key":"251_CR12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/annonc\/mds601","volume":"24","author":"QJ Wu","year":"2013","unstructured":"Q.J. Wu, Y. Yang, E. Vogtmann, J. Wang, L.H. Han, H.L. Li, Y.B. Xiang, Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies. Ann Oncol 24, 1079\u20131087 (2013)","journal-title":"Ann Oncol"},{"key":"251_CR13","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4161\/cc.4.9.1993","volume":"4","author":"BB Aggarwal","year":"2005","unstructured":"B.B. Aggarwal, H. Ichikawa, Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4, 1201\u20131215 (2005)","journal-title":"Cell Cycle"},{"key":"251_CR14","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1158\/0008-5472.CAN-06-4277","volume":"67","author":"D Kong","year":"2007","unstructured":"D. Kong, Y. Li, Z. Wang, S. Banerjee, F.H. Sarkar, Inhibition of angiogenesis and invasion by 3, 3\u2032-Diindolylmethane is mediated by the Nuclear Factor-\u03baB downstream target genes MMP-9 and uPA that regulate bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res 67, 3310\u20133319 (2007)","journal-title":"Cancer Res"},{"key":"251_CR15","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2174\/18715206113139990078","volume":"13","author":"A Aamir","year":"2013","unstructured":"A. Aamir, B. Bernhard, L. Yiwei, K. Dejuan, B. Bin, S. Rainer, B. Subhash, H. Fazlul, Sarkar, Targeted regulation of PI3K\/Akt\/mTOR\/NF-\u03baB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy. Anticancer Agents Med Chem 13, 1002 (2013)","journal-title":"Anticancer Agents Med Chem"},{"key":"251_CR16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/jpet.111.188706","volume":"341","author":"PK Kandala","year":"2012","unstructured":"P.K. Kandala, S.E. Wright, S.K. Srivastava, Blocking epidermal growth factor receptor activation by 3, 3\u2032-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo. J Pharmacol Exp Ther 341, 24\u201332 (2012)","journal-title":"J Pharmacol Exp Ther"},{"key":"251_CR17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cyto.2012.01.015","volume":"58","author":"A Maccio","year":"2012","unstructured":"A. Maccio, C. Madeddu, Inflammation and ovarian cancer. Cytokine 58, 133\u2013147 (2012)","journal-title":"Cytokine"},{"key":"251_CR18","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","volume":"17","author":"J Coward","year":"2011","unstructured":"J. Coward, H. Kulbe, P. Chakravarty, D. Leader, V. Vassileva, D.A. Leinster, R. Thompson, T. Schioppa, J. Nemeth, J. Vermeulen, N. Singh, N. Avril, J. Cummings, E. Rexhepaj, K. Jirstr\u00f6m, W.M. Gallagher, D.J. Brennan, I.A. McNeish, F.R. Balkwill, Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res 17, 6083\u20136096 (2011)","journal-title":"Clin Cancer Res"},{"key":"251_CR19","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","volume":"38","author":"Y Guo","year":"2012","unstructured":"Y. Guo, F. Xu, T. Lu, Z. Duan, Z. Zhang, Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev 38, 904\u2013910 (2012)","journal-title":"Cancer Treat Rev"},{"key":"251_CR20","first-page":"121","volume":"39","author":"G Gastl","year":"2001","unstructured":"G. Gastl, M. Plante, Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Methods Mol Med 39, 121\u2013123 (2001)","journal-title":"Methods Mol Med"},{"key":"251_CR21","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.2174\/138161212802002797","volume":"18","author":"EM Dijkgraaf","year":"2012","unstructured":"E.M. Dijkgraaf, M.J. Welters, J.W. Nortier, S.H. van der Burg, J.R. Kroep, Interleukin-6\/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer. Curr Pharm Des 18, 3816\u20133827 (2012)","journal-title":"Curr Pharm Des"},{"key":"251_CR22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cyto.2012.04.020","volume":"59","author":"Y Wang","year":"2012","unstructured":"Y. Wang, L. Li, X. Guo, X. Jin, W. Sun, X. Zhang, R.C. Xu, Signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells. Cytokine 59, 228\u2013236 (2012)","journal-title":"Cytokine"},{"key":"251_CR23","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-13-1178","volume":"73","author":"N Shah","year":"2013","unstructured":"N. Shah, K. Jin, L.A. Cruz, S. Park, H. Sadik, S. Cho, C.P. Goswami, H. Nakshatri, R. Gupta, H.Y. Chang, Z. Zhang, A. Cimino-Mathews, L. Cope, C. Umbricht, S. Sukumar, HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ER\u03b1 and inducing IL-6 expression. Cancer Res 73, 5449\u20135458 (2013)","journal-title":"Cancer Res"},{"key":"251_CR24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/pros.20350","volume":"66","author":"VPS Garikapaty","year":"2006","unstructured":"V.P.S. Garikapaty, B.T. Ashok, K. Tadi, A. Mittelman, R.K. Tiwari, Synthetic dimer of indole-3-carbinol: second generation diet derived anti-cancer agent in hormone sensitive prostate cancer. Prostate 66, 453\u2013462 (2006)","journal-title":"Prostate"},{"key":"251_CR25","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1158\/1535-7163.MCT-07-0336","volume":"6","author":"KM Rahman","year":"2007","unstructured":"K.M. Rahman, S. Ali, A. Aboukameel, S.H. Sarkar, Z. Wang, P.A. Philip, W.A. Sakr, A. Raz, Inactivation of NF- KB by 3, 3\u2032-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. Mol Cancer Ther 6, 2757\u20132765 (2007)","journal-title":"Mol Cancer Ther"},{"key":"251_CR26","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/sj.onc.1208434","volume":"24","author":"L Xue","year":"2005","unstructured":"L. Xue, G.L. Firestone, L.F. Bjeldanes, DIM stimulates IFNgamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways. Oncogene 24, 2343\u20132353 (2005)","journal-title":"Oncogene"},{"key":"251_CR27","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1038\/onc.2009.130","volume":"28","author":"M Walter","year":"2009","unstructured":"M. Walter, S. Liang, S. Ghosh, P.J. Hornsby, R. Li, Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 28, 2745\u20132755 (2009)","journal-title":"Oncogene"},{"key":"251_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell 100, 57\u201370 (2000)","journal-title":"Cell"},{"key":"251_CR29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"G.P. Gupta, J. Massagu\u00e9, Cancer metastasis: building a framework. Cell 127, 679\u2013695 (2006)","journal-title":"Cell"},{"key":"251_CR30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2012.06.006","volume":"325","author":"B Tu","year":"2012","unstructured":"B. Tu, L. Du, Q.M. Fan, Z. Tang, T.T. Tang, STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma. Cancer Lett 325, 80\u201388 (2012)","journal-title":"Cancer Lett"},{"key":"251_CR31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2005.03.016","volume":"98","author":"S Bellone","year":"2005","unstructured":"S. Bellone, K. Watts, S. Cane, M. Palmieri, M.J. Cannon, A. Burnett, xAlexander BurnettSearch for articles by this author Roman JJ, Pecorelli S, Santin AD, High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and Affiliations Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA chemotherapy-resistant variant of endometrial cancer. Gynecol Oncol 98, 92\u201398 (2005)","journal-title":"Gynecol Oncol"},{"key":"251_CR32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/030089160409000207","volume":"90","author":"N Songur","year":"2004","unstructured":"N. Songur, B. Kuru, F. Kalkan, C. Ozdilekcan, H. Cakmak, N. Hizel, Serum interleukin-6 levels correlate with malnutrition and survival in patients with advanced non-small cell lung cancer. Tumori 90, 196\u2013200 (2004)","journal-title":"Tumori"},{"key":"251_CR33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2559.2005.02178.x","volume":"47","author":"I Garcia-Tunon","year":"2005","unstructured":"I. Garcia-Tunon, M. Ricote, A. Ruiz, B. Fraile, R. Paniagua, M. Royuela, IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma. Histopathology 47, 82\u201389 (2005)","journal-title":"Histopathology"},{"key":"251_CR34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ijc.10833","volume":"103","author":"R Salgado","year":"2003","unstructured":"R. Salgado, S. Junius, I. Benoy, P. Van Dam, P. Vermeulen, E. Van Marck, P. Huget, L. Dirk, Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 103, 642\u2013646 (2003)","journal-title":"Int J Cancer"},{"key":"251_CR35","first-page":"210","volume":"11","author":"I Zakrzewska","year":"2001","unstructured":"I. Zakrzewska, J. Poznanski, Changes of serum IL-6 and CRP after chemotherapy in patients with ovarian carcinoma. Pol Merkur Lekarski 11, 210\u2013213 (2001)","journal-title":"Pol Merkur Lekarski"},{"key":"251_CR36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1525-1438.2000.00003.x","volume":"10","author":"RT Penson","year":"2000","unstructured":"R.T. Penson, K. Kronish, Z. Duan, A.J. Feller, P. Stark, S.E. Cook, L.R. Duska, A.F. Fuller, A.K. Goodman, N. Nikrui, K.M. MacNeill, U.A. Matulonis, F.I. Preffer, M.V. Seiden, Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1. GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int J Gynecol Can 10, 33\u201341 (2000)","journal-title":"Int J Gynecol Can"},{"key":"251_CR37","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/cncr.22293","volume":"107","author":"DG Rosen","year":"2006","unstructured":"D.G. Rosen, I. Mercado-Uribe, G. Yang, R.C. Bast Jr., H.M. Amin, R. Lai, J. Liu, The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer 107, 2730\u20132740 (2006)","journal-title":"Cancer"},{"key":"251_CR38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2174\/156652409788488739","volume":"9","author":"N Iglesia de la","year":"2009","unstructured":"N. de la Iglesia, S.V. Puram, A. Bonni, STAT3 regulation of glioblastoma pathogenesis. Curr Mol Med 9, 580\u2013590 (2009)","journal-title":"Curr Mol Med"},{"key":"251_CR39","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1053\/j.gastro.2009.11.049","volume":"138","author":"M Musteanu","year":"2010","unstructured":"M. Musteanu, L. Blaas, M. Mair, M. Schlederer, M. Bilban, S. Tauber, H. Esterbauer, M. Mueller, E. Casanova, L. Kenner, V. Poli, R. Eferl, Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice. Gastroenterology 138, 1003\u20131011 (2010)","journal-title":"Gastroenterology"},{"key":"251_CR40","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1073\/pnas.1201232109","volume":"109","author":"JP Couto","year":"2012","unstructured":"J.P. Couto, L. Daly, A. Almeida, J.A. Knauf, J.A. Fagin, M. Sobrinho-Simoes, J. Lima, V. Maximo, P. Soares, D. Lyden, J. Bromberg, STAT3 negatively regulates thyroid tumorigenesis. Proc Natl Acad Sci U S A 109, 2361\u20132370 (2012)","journal-title":"Proc Natl Acad Sci U S A"},{"key":"251_CR41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.urology.2006.11.006","volume":"69","author":"JF Torres-Roca","year":"2007","unstructured":"J.F. Torres-Roca, M. DeSilvio, L.B. Mora, L.Y. Khor, E. Hammond, N. Ahmad, R. Jove, J. Forman, R.J. Lee, H. Sandler, A. Pollack, Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86\u201310. Urology 69, 505\u2013509 (2007)","journal-title":"Urology"},{"key":"251_CR42","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3892\/ijo.2012.1533","volume":"41","author":"N Yanaihara","year":"2012","unstructured":"N. Yanaihara, M.S. Anglesio, K. Ochiai, Y. Hirata, M. Saito, C. Nagata, Y. Lida, S. Takakura, K. Yamada, T. Tanaka, A. Okamoto, Cytokine gene expression signature in ovarian clear cell carcinoma. Int J Oncol 41, 1094\u20131100 (2012)","journal-title":"Int J Oncol"},{"key":"251_CR43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1026028303196","volume":"253","author":"S Chakraborti","year":"2003","unstructured":"S. Chakraborti, M. Mandal, S. Das, A. Mandal, T. Chakraborti, Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253, 269\u2013285 (2003)","journal-title":"Mol Cell Biochem"},{"key":"251_CR44","doi-asserted-by":"crossref","unstructured":"S.P. Gao, J.F. Bromberg, Touched and moved by STAT3. Sci. Signaling. 2006, pe30 (2006)","DOI":"10.1126\/stke.3432006pe30"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-015-0251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-015-0251-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-015-0251-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T02:09:00Z","timestamp":1567303740000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-015-0251-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,28]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["251"],"URL":"https:\/\/doi.org\/10.1007\/s13402-015-0251-7","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,28]]}}}